The therapeutic challenge of late antibody-mediated kidney allograft rejection. [electronic resource]
- Transplant international : official journal of the European Society for Organ Transplantation Aug 2019
- 775-788 p. digital
Publication Type: Journal Article; Review
1432-2277
10.1111/tri.13436 doi
Allografts--immunology Animals Antibodies, Monoclonal, Humanized Bortezomib--therapeutic use Graft Rejection--immunology Graft Survival--drug effects Histocompatibility Humans Immunoglobulins, Intravenous--therapeutic use Immunosuppressive Agents--therapeutic use Isoantibodies--blood Kidney Transplantation Proteasome Inhibitors Randomized Controlled Trials as Topic Rituximab--therapeutic use Transplantation, Homologous